{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:30:10Z","timestamp":1786984210464,"version":"build-2736575974"},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.ajog.2015.03.020","type":"journal-article","created":{"date-parts":[[2015,3,11]],"date-time":"2015-03-11T03:49:18Z","timestamp":1426045758000},"page":"650-652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Extended-spectrum \u03b2-lactamase infections during pregnancy: a growing threat"],"prefix":"10.1016","volume":"213","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6436-7301","authenticated-orcid":false,"given":"Catherine S.","family":"Eppes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven L.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2015.03.020_bib1","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/QCO.0b013e3283398dc1","article-title":"Extended-spectrum b-lactamase producing Escherichia coli: changing epidemiology and clinical impact","volume":"23","author":"Oteo","year":"2010","journal-title":"Cur Opin Infect Dis"},{"issue":"Suppl","key":"10.1016\/j.ajog.2015.03.020_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1469-0691.2007.01857.x","article-title":"Defining an extended-spectrum b-lactamase","volume":"14","author":"Livermore","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ajog.2015.03.020_bib3","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0094-0143(05)70218-4","article-title":"Urinary tract infections in pregnancy","volume":"26","author":"Thorp","year":"1999","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.ajog.2015.03.020_bib4","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0889-8545(05)70219-9","article-title":"Urinary tract infections during pregnancy","volume":"28","author":"Gilstrap","year":"2001","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.ajog.2015.03.020_bib5","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1086\/671740","article-title":"Secular trends in Gram-negative resistance among urinary tract infection hospitalizations in the United States, 2000-2009","volume":"34","author":"Zilberberg","year":"2013","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ajog.2015.03.020_bib6","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1056\/NEJMra041359","article-title":"The new beta-lactamases","volume":"352","author":"Jacoby","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2015.03.020_bib7","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1128\/CMR.18.4.657-686.2005","article-title":"Extended-spectrum \u03b2-lactamases: a clinical update","volume":"18","author":"Paterson","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ajog.2015.03.020_bib8","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jhin.2009.02.021","article-title":"Extended-spectrum \u03b2-lactamase-producing organisms","volume":"73","author":"Falagas","year":"2009","journal-title":"J\u00a0Hosp Infect"},{"key":"10.1016\/j.ajog.2015.03.020_bib9","unstructured":"Centers for Disease Control and Prevention. FAQs about ESBLs. Laboratory detection of extended-spectrum \u03b2-lactamases (ESBLs). Available at: http:\/\/www.cdc.gov\/hai\/settings\/lab\/lab_esbl.html. Accessed Oct. 31,\u00a02014."},{"key":"10.1016\/j.ajog.2015.03.020_bib10","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1128\/JCM.37.12.4065-4070.1999","article-title":"Detection and reporting of organisms producing extended-spectrum betalactamases: survey of laboratories in Connecticut","volume":"37","author":"Tenover","year":"1999","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.ajog.2015.03.020_bib11","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s150100050041","article-title":"Occurrence of extended-spectrum \u03b2-lactamases in Dutch hospitals","volume":"27","author":"Stobberingh","year":"1999","journal-title":"Infection"},{"key":"10.1016\/j.ajog.2015.03.020_bib12","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2165\/00003495-200363040-00002","article-title":"Extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae: considerations for diagnosis, prevention and drug treatment","volume":"63","author":"Rupp","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.ajog.2015.03.020_bib13","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1099\/00222615-47-3-201","article-title":"Long-term investigation of the clonal dissemination of Klebsiella pneumoniae isolates producing extended-spectrum \u03b2-lactamases in a university hospital","volume":"47","author":"Branger","year":"1998","journal-title":"J\u00a0Med Microbiol"},{"key":"10.1016\/j.ajog.2015.03.020_bib14","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/jac\/dkp411","article-title":"Bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome","volume":"65","author":"Gudiol","year":"2010","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.ajog.2015.03.020_bib15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1086\/649537","article-title":"Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis","volume":"50","author":"Rodriguez-Bano","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajog.2015.03.020_bib16","series-title":"Performance standards for antimicrobial susceptibility testing; NCCLS approved standard M100\u2013S9","year":"1999"},{"key":"10.1016\/j.ajog.2015.03.020_bib17","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1128\/JCM.42.1.294-298.2004","article-title":"Utility of NCCLS guidelines for identifying extended-spectrum beta-lactamases in non-Escherichia coli and non-Klebsiella spp. of Enterobacteriaceae","volume":"42","author":"Schwaber","year":"2004","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.ajog.2015.03.020_bib18","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/civ003","article-title":"Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum \u03b2-lactamase bacteremia","author":"Tamma","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajog.2015.03.020_bib19","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ijantimicag.2012.08.003","article-title":"Nitrofurantoin in the treatment of extended-spectrum \u03b2-lactamase-producing Escherichia coli\u2013related lower urinary tract infection","volume":"40","author":"Tasbakan","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ajog.2015.03.020_bib20","first-page":"308","article-title":"Fosfomycin: an oral agent for urinary infection caused by extended spectrum beta-lactamase producing organisms","volume":"60","author":"Hutley","year":"2010","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.ajog.2015.03.020_bib21","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijantimicag.2006.08.039","article-title":"Fosfomycin in the treatment of extended spectrum beta-lactamase-producing Escherichia coli\u2013related lower urinary tract infections","volume":"29","author":"Pullukcu","year":"2007","journal-title":"Int J Antimicrob Agents"},{"issue":"Suppl","key":"10.1016\/j.ajog.2015.03.020_bib22","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1469-0691.2007.01852.x","article-title":"Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline","volume":"14","author":"Garau","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ajog.2015.03.020_bib23","series-title":"Drugs in pregnancy and lactation, 10th ed","author":"Briggs","year":"2015"},{"key":"10.1016\/j.ajog.2015.03.020_bib24","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1128\/AAC.45.12.3548-3554.2001","article-title":"Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended spectrum beta-lactamase producing Enterobacteriaceae","volume":"45","author":"Thomson","year":"2001","journal-title":"Antimicrob Agents Chemother"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937815002367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937815002367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:05:36Z","timestamp":1757588736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937815002367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0002937815002367"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2015.03.020","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extended-spectrum \u03b2-lactamase infections during pregnancy: a growing threat","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2015.03.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}